EverQuote (EVER)
(Delayed Data from NSDQ)
$20.04 USD
+0.39 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $20.07 +0.03 (0.15%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.04 USD
+0.39 (1.98%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $20.07 +0.03 (0.15%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth A Momentum B VGM
Zacks News
What Makes EverQuote (EVER) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does EverQuote (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Small-Cap Stocks to Buy Despite Inflation Headwinds
by Nalak Das
We have narrowed our search to five small-cap (market capital < $1 billion) stocks. These stocks are: AXL, EVER, GRC, ROOT, NVRI.
Here's Why Investors Should Hold Corebridge (CRBG) Stock Now
by Zacks Equity Research
Improving premiums, fee and investment income and streamlining initiatives bode well for Corebridge (CRBG).
MetLife (MET) Arm MIM Secures $1.2B for 2nd Private Equity Fund
by Zacks Equity Research
MetLife (MET) Arm, MIM, plans to utilize $250 million on new private equity opportunities.
Wall Street Analysts See a 35.78% Upside in EverQuote (EVER): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 35.8% in EverQuote (EVER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
EverQuote (EVER) Rallies 220% in a Year: What's Driving It?
by Zacks Equity Research
EverQuote (EVER) rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Here's Why Radian Group (RDN) Stock is an Attractive Pick Now
by Zacks Equity Research
Radian Group (RDN) stands to gain from strong persistency rates, improved new insurance written, a strong capital position, favorable growth estimates and effective capital deployment.
Unum (UNM) Shares Gain 12% YTD: Will the Upside Continue?
by Zacks Equity Research
Favorable sales trends and risk experience, strong persistency, an improving rate environment and a solid capital position poise Unum (UNM) well.
Here's Why EverQuote (EVER) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Hold Strategy is Apt for MGIC Investment (MTG)
by Zacks Equity Research
MGIC Investment (MTG) is well-poised to gain from solid insurance in force, a decline in loss and claims payments, better housing market fundamentals and prudent capital deployment.
Reasons Why Investors Should Retain Assurant (AIZ) Stock Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from a well-performing Global Lifestyle business, growth of fee-based capital-light businesses, solid capital management and effective capital deployment.
Reinsurance Group (RGA) Up 28.4% YTD: More Room for Growth?
by Zacks Equity Research
Reinsurance Group (RGA) gains from improved pricing, a solid in-force business, an improving interest rate environment, favorable growth estimates and prudent capital deployment.
Here's Why Hold Strategy is Apt for Voya Financial (VOYA)
by Zacks Equity Research
Voya Financial (VOYA) is well-poised to gain from favorable retention, positive impacts of the Benefitfocus buyout, higher investment income and surplus income.
Here's Why Hold Strategy is Apt for Everest Group (EG) Stock
by Zacks Equity Research
Everest Group (EG) stands to gain from an improved interest rate environment, strong renewal retention, continued favorable rate increases and a solid capital position.
Here's Why Hold Strategy is Apt for CME Group (CME) Stock
by Zacks Equity Research
CME Group (CME) stands to benefit from its global presence, compelling product portfolio and focus on over-the-counter clearing services and optimistic growth projections.
Down -20.94% in 4 Weeks, Here's Why EverQuote (EVER) Looks Ripe for a Turnaround
by Zacks Equity Research
EverQuote (EVER) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Here's Why Hold Strategy is Apt for Prudential Financial (PRU)
by Zacks Equity Research
Prudential Financial (PRU) is well-poised to gain from the growing pension risk transfer market, higher emerging markets earnings, strategic acquisitions and effective capital deployment.
Coinbase Global (COIN) Up 394.8% in a Year: Will the Rally Last?
by Zacks Equity Research
Coinbase Global (COIN) is poised to gain from higher average fees, growing average crypto asset prices, investments in technology, improved Crypto trading and expansion of international operations.
Should You Add Old Republic (ORI) Stock for Better Returns?
by Zacks Equity Research
Old Republic (ORI) stands to gain from higher premiums in commercial auto, financial indemnity and property coverages, favorable growth estimates and a solid balance sheet.
Why EverQuote (EVER) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from higher net added customers, growth in overall average policy value, expanded geographic footprint and a solid capital position.
EverQuote (EVER) Surges 89.6% YTD: Will the Rally Last?
by Zacks Equity Research
EverQuote (EVER) stock rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Why Is EverQuote (EVER) Down 12% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wall Street Analysts Think EverQuote (EVER) Could Surge 34.55%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 34.6% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.